Foreign -funded giants are increasing the food of the domestic over -the -counter drug (OTC) market，Recently, Bayer announced the wholly -owned acquisition of Dianhong Pharmaceutical Group。If the purchase price is expected to be expected to be 3.6 billion yuan，This merger and acquisition will be the largest merger and acquisition case in the domestic OTC field in recent years。Industry insiders expect，With the further improvement of China's global OTC market size and further enhanced competition in the OTC field，Foreign -funded pharmaceutical giants Stake Sports Bettingwill Stake Sports Bettingintensify OTC mergers and acquisitions in China。

    OTC mergers and acquisitions to redevelop fire

    Ruo Bayer's acquisition of Dianhong Pharmaceuticals is indeed 3.6 billion yuan，It means that the OTC M & A field will create a sky -high price，This also makes OTC M & A in silence again appeared in the public view。

    Data display，Dianhong Pharmaceuticals also conducted listed environmental protection inspections at the beginning of last year，But with Hangzhou Jingfeng Pharmaceutical、Similarity of Jichuan Pharmaceuticals in Taizhou，Dianhong Pharmaceutical did not promote the first public offering (IPO)，Instead, choose to become a wholly -owned subsidiary of a stake online sports bettingforeign pharmaceutical company。As for Jingfeng Pharmaceutical and Jichuan Pharmaceutical，By borrowing*ST Tianyi、Hongcheng Co., Ltd.。

    Data display，The domestic OTC market has increased from 25 billion yuan in 2000 to 230 billion yuan in 2012，Although it has entered a slow -growing growth period in recent years，But it will still maintain an average annual growth rate of about 10%。Comparison of comparison，Europe and the United States and other regions OTC markets are generally lower than 5%，Signs of stagnation are more obvious。

    Bayer and other giants facing the predicament overseas are not stopped here，A pharmaceutical researcher in Shenzhen told reporters，Original medicine with patented medicine is the unique weapon of stake online sports bettingforeign Stake Sports Bettingpharmaceutical stake online sports bettingcompanies，But the patent cliff in 2015 is coming，A considerable part of the imported medicine in the world will lose patent protection，Refer to the current data，These original drugs will gradually fall by more than 70%within one year when the patent expires。Subject to a new field in the world gradually becomes one of the important strategies for foreign pharmaceutical companies，and the Chinese OTC market happens to be the target area。

    According to the above researcher analysis，The primary purpose of the acquisition of domestic OTC varieties is not necessarily profitable，Sometimes channels are more critical。Taking Sanofei mergers and acquisition of Sunstone as an example，Except that the Sun Stone has two mainstream OTC products，It is also related to its strong layout in the domestic second and third -tier channels，Sanofi has made it clear that the business layout of the solar stone is very important to see the business layout of the solar stone。

    Foreign -funded pharmaceutical companies, low valleys to bottom out

    Before the merger，Bayer purchased 3 western medicine OTC varieties from Dongsheng Technology (predecessor of Guangyuyuan) for 1.264 billion yuan in 2008，Since then, Bai Jiahe has become a heavy product of Bayer in the field of OTC in China，Bai Jiahei has always been with Sensang、Kuake、Xin Kangtaik and others eat domestic cold OTC market。

    Immediately in October 2010，French Pharmaceutical My stake betting appGiant Sanofi announced stake online sports bettingthat it cost $ 521 million to acquire Meihua Sun Stone Company，The latter was a listed company in Nasdaq，Two OTC varieties of good dolls and Kang women in the Chinese market。

    At that time, the Sanofei mergers and acquisition of Sunstone were called the sky -high M & A in the domestic OTC market，After the merger，Sanofi further expands in the Chinese OTC market，Since then, it has formed a joint venture with Hangzhou Minsheng Pharmaceutical，In order to indirect mergers and acquisitions of vitamin OTC products of Minsheng Pharmaceutical OTC 21 Golden Wei。At the same time，Nicokin, a well -known Swiss Pharmaceutical Group in the global OTC market, entered the Guangdong Tiandu Biochemical Medicine for $ 214 million，This enhances the layout of the Chinese market。

    Within two years，Bayer、Sanofi、The M & A war set off by Nico Ming once shocked the domestic OTC field，The interpreted as a new round of OTC reshuffle is about to start。Since then，Until a few days ago, Bayer announced the wholly -owned acquisition of Dianhong Pharmaceutical，OTC mergers and acquisitions of warfire will be re -ignited。

    According to the reporter's understanding，The entire pharmaceutical market in the country，OTC market does not occupy the dominant position，Prescription medicines through hospital channels are the mainstream。But because OTC faces the market，The competition participating is far more than prescription medicine，Stake Sports BettingOnly the opportunity for stake online sports bettingforeign pharmaceutical companies to mergers and acquisitions。Some analysis believes，In recent years, the domestic OTC market has actually entered a phased trough，A large number of original drug -research patents will soon expire.。